The achievement of molecular complete remission during treatment with Imatinib mesylate correlates with relapse free survival in bcr/abl-positive acute lymphoid leukemia patients.
Academic Article
Publication Date:
2004
CRIS type:
1.1 Articolo in rivista
List of contributors:
Piccaluga, Pp; Malagola, Michele; Amabile, M; Rondoni, M; Paolini, S; Pane, F; Russo, Domenico; Visani, G; Baccarani, M.; Martinelli, G.
Published in: